| |
Non PE group (n=74) |
PE group (n=13) |
p |
| Age, mean ±SD |
66.5 ±11.10 |
70.77 ± 12.33 |
0.212 |
| PE risk factors, n (%) |
31 (41.9%) |
7 (53.8) |
0.307 |
| Cancer history, n (%) |
10 (13.5) |
3 (23.1) |
0.3 |
| GOLD III and IV, n (%) |
47 (64.4%) |
9 (69.2%) |
0.552 |
| FEV1 (% pred), mean±SD |
41.6 ±17.1 |
47.1 ±15.9 |
0.28 |
| Intensive care unit, n (%) |
35 (48.6%) |
9 (69.2%) |
0.143 |
| Wells score, mean± SD |
4.42± 1.29 |
5.23 ± 1.23 |
0.04 |
| Wells score higher than 5, n (%) |
14 (18.9) |
6 (46.2) |
0.04 |
| Geneve score, mean ± SD |
4.68 ± 1.68 |
5.23± 1.59 |
0.278 |
| Increased cough, n (%) |
50 (67.6%) |
3 (23.1%) |
0 |
| Increased sputum volume, n (%) |
47 (63.5%) |
6 (46.2%) |
0.19 |
| Chest pain, n (%) |
9 (12.2%) |
2 (15.4%) |
0.517 |
| D Dimer (µg/mL), mean± SD |
1.50±0.98 |
2.24±1.16 |
0.02 |
| PaO2/FiO2ratio, mean±SD |
242.9±73.9 |
263.1±106.9 |
0.439 |
| PaCO2 (mmHg) mean±SD |
54.53±20.06 |
46.72±14.49 |
0.183 |
| Lactate (mmol/L), mean±SD |
1.82±0.99 |
1.82±0.45 |
0.992 |
| pH, mean±SD |
7.34±0.99 |
7.36±0.83 |
0.479 |
| CRP (mg/mL), mean±SD |
70.87±74.88 |
61.38±97.15 |
0.688 |
| Troponin (ng/mL), mean±SD |
0.14±0.54 |
0.22±0.29 |
0.62 |
| BNP (ng/mL), mean±SD |
350.57±474.27 |
343.40±336.98 |
0.964 |
|
